Conray 30 and Insulin aspart protamine and insulin aspart Subcutaneous
Determining the interaction of Conray 30 and Insulin aspart protamine and insulin aspart Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: iothalamate
Brand name: Conray, Conray 30, Conray 43, Cysto-Conray II
Synonyms: Iothalamate Meglumine
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin aspart and insulin aspart protamine, Insulin Aspart Protamine and Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Conray 30-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Conray 30-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Conray 30-Insulin Aspart Protamine Injection
- Conray 30-Insulin aspart, recombinant Subcutaneous
- Conray 30-Insulin degludec
- Conray 30-Insulin Degludec (U-100) Prefilled Pens
- Insulin aspart protamine and insulin aspart Subcutaneous-Conray 400
- Insulin aspart protamine and insulin aspart Subcutaneous-Conray 43
- Insulin aspart protamine and insulin aspart Subcutaneous-Consensi
- Insulin aspart protamine and insulin aspart Subcutaneous-Constulose
- Insulin aspart protamine and insulin aspart Subcutaneous-Contac 12-Hour
- Insulin aspart protamine and insulin aspart Subcutaneous-Contac Cold